Provention Bio Inc
Biotechnology
Healthcare
PRVB
83.12 M shares
NASDAQ US
traded
26 Apr 2023
listed
yes
open
24.99
52 week high
24.98
high
25.00
52 week low
3.43
low
24.98
growth
482.28 %
previous Close
24.23
P/E ratio
market cap
647 M
div yield
0
net incoming
-28.63 M
3.55 %
net profit margin
-3787.43 %
192.00 %
operating incoming
-29.08 M
2.53 %
net change in cash
44.50 M
361.34 %
cash on hand
102 M
76.88 %
top